Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
It is important to note, however, that Retatrutide is still in Phase 3 clinical trials (the TRIUMPH programme), and its full regulatory approval is expected in 20262027
"A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1)"
The use of compounded drugs in patients using GLP-1s without medical supervision pose significant risk and can result in significant consequences, said Marina Basina, MD, a clinical professor in endocrinology, gerontology and metabolism
P., Knight, H., Wang, D., Morrow, S., Heath, L., Jebb, S
The GLP-1 hormone showed powerful glucose-lowering effects and appetite-suppressing properties, making it a prime candidate for therapeutic development
Ready to take the next step
US$ 24.38
US$ 22.55
US$ 29.60
US$ 26.66
US$ 23.77
US$ 26.90
US$ 24.23
US$ 29.63
US$ 21.12
